Sepsis-induced alteration in T-cell Ca(2+) signaling in neonatal rats

M H Alattar1, T M Ravindranath, M A Choudhry

  • 1Burn and Shock Trauma Institute, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA.

Biology of the Neonate
|October 20, 2001
PubMed

Insights

Sepsis suppresses T-cell proliferation in neonatal rats by disrupting calcium signaling. Prostaglandin E2 (PGE2) plays a key role, with cyclooxygenase-2 (COX-2) inhibition protecting T-cell function.

Area of Science:

  • Immunology
  • Neonatal Sepsis Research
  • Calcium Signaling

Background:

  • Sepsis impairs T-cell proliferation, a critical immune response.
  • Previous studies indicated T-cell dysfunction in septic adult rats.
  • Neonatal sepsis also shows suppressed T-cell proliferation.

Purpose of the Study:

  • To investigate sepsis-induced alterations in splenic T-cell cytosolic calcium concentration ([Ca(2+)](i)) in neonatal rats.
  • To explore the role of prostaglandin E2 (PGE2) in sepsis-related changes in T-cell [Ca(2+)](i).
  • To assess the impact of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibition on T-cell calcium signaling during neonatal sepsis.

Main Methods:

  • Sepsis was induced in 15-day-old rat pups using fecal pellets.
  • T-cells were isolated from spleens of septic, sham, and control pups.
  • Fura-2 fluorophotometry measured T-cell [Ca(2+)](i) responses to concanavalin A (ConA) stimulation.
  • Animals were pretreated with COX-1 (resveratrol) or COX-2 (NS-398) inhibitors.

Main Results:

  • ConA-mediated T-cell [Ca(2+)](i) response was significantly suppressed in septic neonatal rats.
  • Pretreatment with a COX-2 inhibitor, but not a COX-1 inhibitor, prevented this suppression.
  • These findings implicate PGE2 in the T-cell calcium signaling deficits observed during neonatal sepsis.

Conclusions:

  • Neonatal sepsis significantly impairs T-cell calcium signaling.
  • PGE2, mediated by COX-2, contributes to the suppression of T-cell calcium responses during sepsis.
  • Targeting COX-2 may offer a therapeutic strategy to restore T-cell function in neonatal sepsis.

Related Concept Videos